These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2381062)

  • 1. [NK- and T-cell granular lymphocyte-proliferative disorders].
    Sakata T; Amano M; Yamada K; Oshimi K; Kobayashi Y; Togawa A
    Rinsho Ketsueki; 1990 Apr; 31(4):462-7. PubMed ID: 2381062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory findings and clinical courses of 33 patients with granular lymphocyte-proliferative disorders.
    Oshimi K; Yamada O; Kaneko T; Nishinarita S; Iizuka Y; Urabe A; Inamori T; Asano S; Takahashi S; Hattori M
    Leukemia; 1993 Jun; 7(6):782-8. PubMed ID: 8388971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of non-MHC-restricted cytotoxicity by CD45 but not CD3 monoclonal antibodies in patients with large granular lymphoproliferative disease.
    Starling GC; Davidson SE; Nimmo JC; Beard ME; Hart DN
    Clin Exp Immunol; 1989 Dec; 78(3):396-401. PubMed ID: 2532991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristic expansion of CD45RA CD27 CD28 CCR7 lymphocytes with stable natural killer (NK) receptor expression in NK- and T-cell type lymphoproliferative disease of granular lymphocytes.
    Mitsui T; Maekawa I; Yamane A; Ishikawa T; Koiso H; Yokohama A; Handa H; Matsushima T; Tsukamoto N; Murakami H; Nojima Y; Karasawa M
    Br J Haematol; 2004 Jul; 126(1):55-62. PubMed ID: 15198732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes.
    Lanier LL; Le AM; Civin CI; Loken MR; Phillips JH
    J Immunol; 1986 Jun; 136(12):4480-6. PubMed ID: 3086432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell receptor delta gene organization and expression in normal and leukemic natural killer cells.
    Biondi A; Allavena P; Rossi V; Bassan R; Barbui T; Champagne E; Mak TW; Minden MD; Rambaldi A; Mantovani A
    J Immunol; 1989 Aug; 143(3):1009-14. PubMed ID: 2526173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation via the CD3 and CD16 pathway mediates interleukin-2-dependent autocrine proliferation of granular lymphocytes in patients with granular lymphocyte proliferative disorders.
    Hoshino S; Oshimi K; Teramura M; Mizoguchi H
    Blood; 1991 Dec; 78(12):3232-40. PubMed ID: 1835892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical analysis of 52 patients with granular lymphocyte proliferative disorder (GLPD) showed frequent anemia in indolent T-cell GLPD in Japan.
    Kawahara S; Sasaki M; Isobe Y; Ando J; Noguchi M; Koike M; Hirano T; Oshimi K; Sugimoto K
    Eur J Haematol; 2009 Apr; 82(4):308-14. PubMed ID: 19220421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphoproliferative disorder of granular lymphocytes: nine cases including one with features of CD56 (NKH1)-positive aggressive natural killer cell lymphoma.
    Nichols GE; Normansell DE; Williams ME
    Mod Pathol; 1994 Oct; 7(8):819-24. PubMed ID: 7530849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the T cell receptor in the lymphoproliferative disease of granular lymphocytes: superantigen activation of clonal CD3+ granular lymphocytes.
    Zambello R; Trentin L; Facco M; Cerutti A; Sancetta R; Milani A; Raimondi R; Tassinari C; Agostini C; Semenzato G
    Cancer Res; 1995 Dec; 55(24):6140-5. PubMed ID: 8521405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of non-major histocompatibility complex-restricted cytotoxicity in patients with granular lymphocyte-proliferative disorders associated with or unassociated with severe anemia.
    Oshimi K; Oshimi Y; Motoji T; Mizoguchi H
    Am J Hematol; 1992 Jun; 40(2):93-7. PubMed ID: 1585924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Aggressive natural killer cell lymphoproliferative disease of large granular lymphocytes with leukemia-like clinical course in the terminalstage].
    Tsukada T; Ohno T; Morita K; Otsuji H; Sekine T; Nishikawa M; Kobayashi T; Kita K; Shirakawa S; Namba K
    Rinsho Ketsueki; 1991 Feb; 32(2):162-6. PubMed ID: 2027242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD3-negative natural killer cells express zeta TCR as part of a novel molecular complex.
    Anderson P; Caligiuri M; Ritz J; Schlossman SF
    Nature; 1989 Sep; 341(6238):159-62. PubMed ID: 2528695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic, functional, and molecular genetic studies of human natural killer cells and cytotoxic T lymphocytes not restricted by the major histocompatibility complex.
    Lanier LL; Le AM; Cwirla S; Federspiel N; Phillips JH
    Fed Proc; 1986 Nov; 45(12):2823-8. PubMed ID: 3095151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrastructural morphology of granular lymphocytes (GL) from patients with immunophenotypically homogeneous expansions of GL populations (GLE).
    Prasthofer EF; Barton JC; Zarcone D; Grossi CE
    J Submicrosc Cytol; 1987 Apr; 19(2):345-54. PubMed ID: 3496466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cell morphology and surface markers in three patients with granular lymphocyte proliferative disorders of the T-cell type].
    Mishima M; Harada K; Kozono T; Maruyama I
    Rinsho Byori; 1994 Jan; 42(1):94-9. PubMed ID: 8107290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-12 is involved in the activation of CD3+ granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes.
    Zambello R; Trentin L; Cassatella MA; Raimondi R; Cerutti A; Enthammer C; Facco M; Agostini C; Semenzato G
    Br J Haematol; 1996 Feb; 92(2):308-14. PubMed ID: 8602990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferential proliferation of natural killer cells among peripheral blood mononuclear cells cocultured with B lymphoblastoid cell lines.
    Perussia B; Ramoni C; Anegon I; Cuturi MC; Faust J; Trinchieri G
    Nat Immun Cell Growth Regul; 1987; 6(4):171-88. PubMed ID: 2960890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial activation of human natural killer cells. Characteristics of the activation process and identification of the effector cell.
    Tarkkanen J; Saksela E; Lanier LL
    J Immunol; 1986 Oct; 137(8):2428-33. PubMed ID: 3093576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chronic proliferative disease of large granular lymphocytes.
    Bassan R; Rambaldi A; Barbui T
    Haematologica; 1989; 74(1):85-94. PubMed ID: 2498190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.